Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration-Reference-Cited by-同舟云学术

Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration

Published:2018-09 Issue:5 Volume:12 Page:1146-1150
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Wójcik Cezary,Fazio Sergio,McIntyre Adam D.,Hegele Robert A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Genetic determinants of plasma triglycerides;Johansen;J Lipid Res,2011

2. Polygenic risk for hypertriglyceridemia can mimic a major monogenic mutation;Stahel;Ann Intern Med,2017

3. Mechanism of action of fibrates on lipid and lipoprotein metabolism;Staels;Circulation,1998

4. Triglycerides, atherosclerosis, and cardiovascular outcome studies: focus on omega-3 fatty acids;Handelsman;Endocr Pract,2017

5. Epidemiology of hypertriglyceridemia and cardiovascular disease;Austin;Am J Cardiol,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring associations between estrogen and gene candidates identified by coronary artery disease genome-wide association studies;2024-08-30

2. Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants;Journal of Clinical Lipidology;2023-09

3. Case Report: Successful Management of a 29-Day-Old Infant With Severe Hyperlipidemia From a Novel Homozygous Variant of GPIHBP1 Gene;Frontiers in Pediatrics;2022-03-10

4. Hypertriglyceridemia: An Infrequent, Difficult-to-predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration;Current Vascular Pharmacology;2020-04-24

5. Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias;BMC Medical Genomics;2020-02-10